Hovens, M M C <br/><br/>
Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Aug 2008 
 - 668-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2007.00794.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aspirin--administration & dosage<br/>Atherosclerosis--drug therapy<br/>C-Reactive Protein--drug effects<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Angiopathies--prevention & control<br/>Female<br/>Humans<br/>Interleukin-6--metabolism<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prospective Studies<br/>Treatment Outcome